"
Use of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer: A Real-Life Experience in Morocco"
written by Diango Keita, Sara Nejjari, Abir Oufrid, Samia El Hakym, Hafssa El Hilali, Chaymae Chbihi, Basma Aabboub, Mounir Belcadi, Mehdi Alem, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas,
published by
Journal of Cancer Therapy,
Vol.17 No.4, 2026
has been cited by the following article(s):